SCHEMBL7147448

SCHEMBL7147448

CC(C)(C)OCCOc1cc(NC(=O)OC(C)(C)C)c([N+](=O)[O-])cc1I

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 3/20 0.39
RAB9A P51151 3/20 0.39
CYP1A2 P05177 2/20 0.39
CYP2C9 P11712 1/20 0.39
KDM4E B2RXH2 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.36
KMT2A Q03164 3/20 0.36
ALDH1A1 P00352 3/20 0.36
MAPK1 P28482 2/20 0.36
MAPT P10636 2/20 0.36
LMNA P02545 1/20 0.36
MMP1 P03956 1/20 0.36
MMP2 P08253 1/20 0.36
MMP9 P14780 1/20 0.36
MMP8 P22894 1/20 0.36
MMP13 P45452 1/20 0.36
MEN1 O00255 2/20 0.34
GLA P06280 1/20 0.34
CASP3 P42574 1/20 0.34
HTT P42858 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7141800 0.91 NPC1 (0.41) NPC1RAB9ACYP1A2CYP2C9KDM4E
SCHEMBL7704609 0.89 KDM4E (0.43) NPC1RAB9ACYP1A2CYP2C9KDM4E
SCHEMBL7141773 0.89 ALDH1A1 (0.42) NPC1RAB9ACYP1A2CYP2C9KDM4E
SCHEMBL7698485 0.86 MEN1 (0.40) NPC1RAB9ACYP1A2CYP2C9SMN1; SMN2
SCHEMBL7144299 0.86 TDP1 (0.40) NPC1RAB9ACYP1A2CYP2C9SMN1; SMN2
SCHEMBL6166451 0.85 CYP1A2 (0.37) NPC1RAB9ACYP1A2CYP2C9KMT2A
SCHEMBL7145419 0.84 MMP1 (0.39) NPC1RAB9ACYP1A2SMN1; SMN2KMT2A
SCHEMBL7141612 0.84 PKM (0.43) SMN1; SMN2KMT2AALDH1A1MAPTMMP1
SCHEMBL7147417 0.84 NPC1 (0.36) NPC1RAB9ACYP1A2CYP2C9SMN1; SMN2
SCHEMBL7141508 0.84 ALDH1A1 (0.36) NPC1RAB9ACYP1A2CYP2C9KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1224174-B1 BENZODIAZEPINE DERIVATIVES AS METABOTROPIC GLUTAMATE RECEPTOR ANTAGONISTS HOFFMANN LA ROCHE (CH) 2003-09-17 EP disclosed
EP-1224174-A2 BENZODIAZEPINE DERIVATIVES AS METABOTROPIC GLUTAMATE RECEPTOR ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2002-07-24 EP disclosed
US-6407094-B1 4-5-DIDEHYDRO-1,5-BENZODIAZEPIN-2-ONE DERIVATIVES; PSYCHOLOGICAL, NERVOUS SYSTEM, AND BRAIN DISORDERS; COGNITION ACTIVATORS; ALZHEIMER*S DISEASE, SCHIZOPHRENIA HOFFMANN-LA ROCHE INC. 2002-06-18 US disclosed
WO-2001029011-A2 BENZODIAZEPINE DERIVATIVES AS METABOTROPIC GLUTAMATE RECEPTOR ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2001-04-26 WO disclosed